Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 2
Submit an article Journal homepage
28
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Tc-99m Labelled Anti CD 66 Antigranulocyte Antibody Imaging for Assessment of Bone Marrow Reserve

Alexander Matthies Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, 53105, Germany
, M.D.,
M. Reinhardt Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, 53105, Germany
,
H. Palmedo Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, 53105, Germany
,
S. Ezziddin Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, 53105, Germany
,
B. Abramowski Department of Obstetrics and Gynecology, University Hospital Bonn, Bonn, Germany
,
W. Kuhn Department of Obstetrics and Gynecology, University Hospital Bonn, Bonn, Germany
,
H.-J. Biersack Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, 53105, Germany
&
D. von Mallek Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, 53105, Germany
 show all
Pages 119-122 | Published online: 11 Jun 2009

References

  • Hartman, A R.; Fleming, G F.; Dillon, J J. Meta-analysis of adjuvant cyclophosphamide/ methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen-receptor, node-positive breast cancer. Clin. Breast Cancer 2001, 2, 138–143. [PUBMED], [INFOTRIEVE], [CSA]
  • Amadori, D.; Nanni, O.; Marangolo, M.; Pacini, P.; Ravaioli, A.; Rossi, A.; Gambi, A.; Catalano, G.; Perroni, D.; Scarpi, E.; Giunchi, D C.; Tienghi, A.; Becciolini, A.; Volpi, A. Disease free survival advantage of adjuvant cyclophosphamide, methotrexate and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomised multicenter study. J. Clin. Oncol. 2000, 18, 3125–3134. [PUBMED], [INFOTRIEVE]
  • Zambetti, M.; Valagussa, P.; Bonadonna, G. Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results. Ann. Oncol. 1996, 7, 481–485. [PUBMED], [INFOTRIEVE]
  • Coombes, R C.; Bliss, J M.; Wils, J.; Morvan, F.; Espie, M.; Amadori, D.; Gambrosier, P.; Richards, M.; Aapro, M.; Villar-Grimalt, A.; McArdle, C.; Perez-Lopez, F R.; Vassilopoulos, P.; Ferreira, E P.; Chilvers, C E.; Coombes, G.; Woods, E M.; Marty, M. Adjuvant cyclophosphamide, methotrexate and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group. J. Clin. Oncol. 1996, 14, 35–45. [PUBMED], [INFOTRIEVE]
  • Crivellari, D.; Bonetti, M.; Castiglione–Gertsch, M.; Gelber, R D.; Rudenstam, C M.; Thurlimann, B.; Price, K N.; Coates, A S.; Hurny, C.; Bernhard, J.; Lindtner, J.; Collins, J.; Senn, H J.; Cavalli, F.; Forbes, J.; Gudgeon, A.; Simoncini, E.; Cortes-Funes, H.; Veronesi, A.; Fey, M.; Goldhirsch, A. Burdens and benefits of adjuvant cyclophosphamide, methotrexate and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J. Clin. Oncol. 2000, 18, 1412–1422. [PUBMED], [INFOTRIEVE]
  • Rosner, G L.; Hargis, J B.; Hollis, D R.; Budman, D R.; Weiss, R B.; Henderson, I C.; Schilsky, R L. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J. Clin. Oncol. 1996, 14, 3000–3008., [PUBMED], [INFOTRIEVE]
  • Henderson, I C.; Berry, D A.; Demetri, G D.; Cirrincione, C T.; Goldstein, L J.; Martino, S.; Ingle, J N.; Cooper, M R.; Hayes, D F.; Tkaczuk, K H.; Fleming, G.; Holland, J F.; Duggan, D B.; Carpenter, J T.; Frei, E.; Schilsky, R L.; Wood, W C.; Muss, H B.; Norton, L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J. Clin. Oncol. 2003, 21 (6), 976–983. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Duncker, C M.; Carrio, I.; Berna, L.; Estorch, M.; Alonso, C.; Ojeda, B.; Blanco, R.; Germa, J R.; Ortega, V. Radioimmunoimaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J. Nucl. Med. 1990, 31, 1450–1455. [PUBMED], [INFOTRIEVE]
  • Reske, S N.; Karstens, J H.; Gloeckner, W M.; Steinstrasser, A.; Schwarz, A.; Ammon, J.; Bull, U. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989, 8633), 299–301. [CROSSREF]
  • Limouris, G S.; Voliotopoulos, V.; Stavraka, A.; Vlahos, L. Tc-99m-Antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases. Anticancer Res. 1997, 17, 1615–1618. [PUBMED], [INFOTRIEVE], [CSA]
  • Becker, W.; Borst, U.; Fischbach, W.; Pasurka, B.; Schaefer, R.; Boerner, W. Kinetic data of in–vivo labelled granulocytes in humans with a murine Tc-99m labelled monoclonal antibody. Eur. J. Nucl. Med. 1989, 15, 361–366. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Von Mallek, D.; Joe, A.; Palmedo, H.; Matthies, A.; Biersack, H.-J.; Reinhardt, M. Improved diagnosis of advanced bone marrow metastases by means of radiolabeled antigranulocyte antibodies. J. Exp. Clin. Cancer Res. 2002, 21, 421–424. [PUBMED], [INFOTRIEVE], [CSA]
  • Reske, S N. Recent advances in bone marrow scanning. Eur. J. Nucl. Med. 1991, 18, 203–221. [PUBMED], [INFOTRIEVE]
  • Munz, D L.; Sandrock, D.; Rilinger, N. Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow. Lancet 1990, 336 (8709), 258–259. [PUBMED], [INFOTRIEVE], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.